Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe COVID-19”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05451654
What this trial is testing

NanoMn®_COVID-19 A Prospective, Multicenter, Randomized, Placebo-controlled, Parallel-group, Double-blind Trial to Evaluate the Clinical Efficacy of NanoManganese® on Top of Standard of Care, in Adult Patients With Moderate to Severe Coronavirus Disease 2019 (COVID-19)

Who this might be right for
COVID-19 Pandemic
Medesis Pharma SA 7
Early research (Phase 1)Ended earlyNCT04762186
What this trial is testing

Viable Human SARS-CoV-2 Specific T Cell Transfer in Patients at Risk for Severe COVID-19

Who this might be right for
Moderate COVID-19-infection
Universitätsklinikum Köln 1
Testing effectiveness (Phase 2)WithdrawnNCT04561180
What this trial is testing

Study to Evaluate the Efficacy and Safety of EG-009A Compared to DEX in Patients With COVID-19 Pneumonia

Who this might be right for
COVID-19 Pneumonia
Evergreen Therapeutics, Inc.
Not applicableUnknownNCT06490744
What this trial is testing

Evolution of Respiratory Function in Lung Transplant Patients With Moderate to Severe Covid-19 Infection

Who this might be right for
COVID-19 Respiratory Infection
University Hospital, Strasbourg, France 75
Testing effectiveness (Phase 2)Ended earlyNCT04416048
What this trial is testing

Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19

Who this might be right for
COVID-19
Charite University, Berlin, Germany 111
Early research (Phase 1)Ended earlyNCT05487040
What this trial is testing

Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease

Who this might be right for
COVID-19
Pfizer 15
Testing effectiveness (Phase 2)WithdrawnNCT03376854
What this trial is testing

Pilot RCT of Therapeutic Hypothermia Plus Neuromuscular Blockade in COVID-19 Patients With ARDS

Who this might be right for
Respiratory Distress Syndrome, AdultSars-CoV2
University of Maryland, Baltimore
Not applicableStudy completedNCT04349618
What this trial is testing

Ultraprotective Ventilation Without Extracorporeal Circulation During COVID 19 Pneumonia

Who this might be right for
Acute Respiratory Distress SyndromeCOVID19Sars-CoV2+1 more
Hospices Civils de Lyon 220
Testing effectiveness (Phase 2)UnknownNCT04760821
What this trial is testing

Prevention of Acute Myocardial Injury by Trimetazidine in Patients Hospitalized for COVID-19

Who this might be right for
Acute Respiratory Distress SyndromeCovid19Myocardial Injury
Ministry of Health, Brazil 80
Testing effectiveness (Phase 2)Ended earlyNCT05226533
What this trial is testing

Clinical Trials to Assess Safety and Efficacy of DWRX2003 Combination With Remdesivir in Moderate to Severe COVID-19 Patients.

Who this might be right for
COVID-19
Daewoong Pharmaceutical Co. LTD. 1
Testing effectiveness (Phase 2)UnknownNCT04321993
What this trial is testing

Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients

Who this might be right for
COVID-19
Lisa Barrett 363
Large-scale testing (Phase 3)UnknownNCT05096052
What this trial is testing

PROlectin M, a Nucleocapsid TErminal GaleCTin Antagonist for COVID-19

Who this might be right for
COVID-19COVID-19 PandemicCOVID-19 Respiratory Infection+2 more
Bioxytran Inc. 408
Not applicableStudy completedNCT04492501
What this trial is testing

Investigational Treatments for COVID-19 in Tertiary Care Hospital of Pakistan

Who this might be right for
Covid19Cytokine Release SyndromeCritical Illness+1 more
UNICEF 600
Post-approval studies (Phase 4)UnknownNCT04359316
What this trial is testing

Azithromycin in Hospitalized COVID-19 Patients

Who this might be right for
COVID-19
Shahid Beheshti University of Medical Sciences 40
Testing effectiveness (Phase 2)Study completedNCT04427098
What this trial is testing

Enoxaparin in COVID-19 Moderate to Severe Hospitalized Patients

Who this might be right for
COVID-19
IRCCS Azienda Ospedaliero-Universitaria di Bologna 301
Large-scale testing (Phase 3)Study completedNCT04358081
What this trial is testing

Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease

Who this might be right for
Covid-19
Novartis Pharmaceuticals 20